about
Decellularized matrices for cardiovascular tissue engineeringAntibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease.Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-α-dependant interleukin-17.Autologous subcutaneous adipose tissue transplants improve adipose tissue metabolism and reduce insulin resistance and fatty liver in diet-induced obesity ratsImmunologic basis of graft rejection and tolerance following transplantation of liver or other solid organsAutologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.Facial and hand allotransplantationChronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens.B-lymphocyte lineage cells and the respiratory system.Endothelium and regulatory inflammatory mechanisms during organ rejection.T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease.Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.Anti-major histocompatibility complex-induced obliterative airway disease: selective role for CD4 and CD8 T cells in inducing immune responses to self-antigens."Mouse Clone Model" for evaluating the immunogenicity and tumorigenicity of pluripotent stem cells.Profiling of differentially expressed genes in haemophilia A with inhibitor.Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection.
P2860
Q27011803-FA7473EB-F56F-4938-9EC1-0F2F85DE1F2BQ34382434-7DD92D53-ADDE-42F7-9910-E92B10242A58Q36292047-9E84B856-A6C4-48FC-851D-D553DE6EB29FQ37263899-DB8CCFAD-9B58-4E3D-907B-509408042118Q37400370-DC8A9001-38D1-46B0-A693-4F832C5E616CQ37528715-D405196D-8E62-4491-8ABE-F64AD9DEB201Q37604294-6495C152-BCE8-4F2B-BBD6-3DCA3D6C353CQ38053174-B88C77CE-8C25-4B89-89AA-DB823EC683BAQ38094250-C28ECFA5-B473-4419-AC36-28B9B67C2B79Q38103486-2259D6E4-49CB-4961-88D2-AA31E4A1605EQ41966454-13F29F8C-CB33-49C8-A34E-0A0AFC8F503EQ42424933-B1E7C6FF-7077-4D1D-AEEE-F704C4BB65E4Q43115823-8877DD45-D603-4AC8-A36C-B5BC55F1526CQ43122736-244C414B-EAC5-4946-A328-B993451ED642Q45875915-1CBEC8EB-E625-4189-AB94-3D2B97369EB8Q47999795-0132C6A4-E569-4165-B0BC-289C0BB4917A
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Alloimmunity and autoimmunity in chronic rejection
@ast
Alloimmunity and autoimmunity in chronic rejection
@en
Alloimmunity and autoimmunity in chronic rejection
@nl
type
label
Alloimmunity and autoimmunity in chronic rejection
@ast
Alloimmunity and autoimmunity in chronic rejection
@en
Alloimmunity and autoimmunity in chronic rejection
@nl
prefLabel
Alloimmunity and autoimmunity in chronic rejection
@ast
Alloimmunity and autoimmunity in chronic rejection
@en
Alloimmunity and autoimmunity in chronic rejection
@nl
P2093
P2860
P1476
Alloimmunity and autoimmunity in chronic rejection
@en
P2093
Anil Seetharam
T Mohanakumar
Venkataswarup Tiriveedhi
P2860
P304
P356
10.1097/MOT.0B013E32833B31F4
P577
2010-08-01T00:00:00Z